Key statistics dashboard for Tenaya Therapeutics, Inc. (TNYA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small mol...
Stock Data
| Price | $0.66 |
| Market Cap | $143M |
| Enterprise Value | $68.6M |
| Beta | 3.00 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.25 |
| Price / Book | 2.07 |
| P/S | 107.29 |
| EV/EBITDA | -0.71 |
| EV/Sales | 51.37 |
| EV/FCF | -0.95 |
| P/FCF | -1.99 |
| Earnings Yield | -72.06% |
| FCF Yield | -50.33% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 263.67% |
| EBIT Margin | -7723.97% |
| EBITDA Margin | -7188.09% |
| Operating Margin | -7929.89% |
| Net Margin | -7723.97% |
| Return on Equity | -108.05% |
| Return on Assets | -110.24% |
| Return on Invested Capital | -136.78% |
| Return on Capital Employed | -142.06% |
Financial Health
| Current Ratio | 4.52 |
| Quick Ratio | 4.52 |
| Cash Ratio | 4.11 |
| Debt / Equity | 0.06 |
| Debt / Assets | 4.22% |
| Net Debt / EBITDA | 0.77 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.36 |
Per-Share Data
| Revenue per share | 0.01 |
| Book Value per share | 0.32 |
| Cash per share | 0.36 |
| FCF per share | -0.33 |
| Tangible Book Value per share | 0.32 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 6 |
| Avg rating (1-5) | 1.00 |
Related companies: ABEO · CRBU · ENTA · FHTX · HUMA · IMRX · NAUT
Explore sector: Healthcare · Biotechnology
More sections of TNYA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks